Cicatricial Alopecias

    May 2017 in “ InTech eBooks
    Ibrahim Halil Yavuz, Göknur Özaydın Yavuz, Serap Gunes Bilgili
    Image of study
    TLDR Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.
    The document from 2017 provides an overview of Primary Cicatricial Alopecias (PCA), a group of disorders causing irreversible hair loss due to scarring from inflammation. It details the clinical features, diagnosis, and treatment of various PCAs, including lymphocytic types like lichen planopilaris and discoid lupus erythematosus, and neutrophilic types like folliculitis decalvans. Treatments range from corticosteroids to immunomodulatory drugs, with variable effectiveness. The document also describes other forms of cicatricial alopecia, such as classic pseudopelade of Brocq, central centrifugal cicatricial alopecia (CCCA), alopecia mucinosa, keratosis follicularis spinulosa decalvans (KFSD), and acne-related conditions. It notes the challenges in treatment, as many patients do not respond well and may relapse, underscoring the need for accurate diagnosis and comprehensive management.
    Discuss this study in the Community →

    Research cited in this study

    25 / 25 results

    Related Community Posts Join

    6 / 289 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  119 upvotes 6 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Related Research

    2 / 2 results